|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/519 | (2006.01) |
| A61K 9/10 | (2006.01) | ||
| A61P 25/18 | (2006.01) | ||
| A61P 25/24 | (2006.01) | ||
| A61K 9/00 | (2006.01) |
| (11) | Number of the document | 3280416 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16777058.5 |
| Date of filing the European patent application | 2016-03-30 | |
| (97) | Date of publication of the European application | 2018-02-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-22 |
| (46) | Date of publication of the claims translation | 2020-06-25 |
| (86) | Number | PCT/US2016/024841 |
| Date | 2016-03-30 |
| (87) | Number | WO 2016/164218 |
| Date | 2016-10-13 |
| (30) | Number | Date | Country code |
| 201562144054 P | 2015-04-07 | US | |
| 201562162596 P | 2015-05-15 | US |
| (72) |
GOPAL, Srihari, US
RAVENSTIJN, Paulien Gerarda Maria, BE
RUSSU, Alberto, BE
SAMTANI, Mahesh Narain, US
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Ilgo veikimo injekcinių paliperidono esterių praleistų dozių dozavimo režimai |
| DOSING REGIMEN FOR MISSED DOSES FOR LONG-ACTING INJECTABLE PALIPERIDONE ESTERS |
| Payment date | Validity (years) | Amount | |
| 2025-02-27 | 10 | 231.00 EUR |
| 2026-03-30 |